TCL Archive Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting. April 1, 2005
TCL Archive NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept May 22, 1981
TCL Archive Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science October 12, 2012
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
